EPGNY

Epigenomics (QX) Share Price

7.769691
0.00 (0.0%)
7.769691
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Epigenomics AG (QX) EPGNY OTCMarkets Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 7.769691 16:33:59
Open Price Low Price High Price Close Price Prev Close
7.769691 7.769691
Bid Price Ask Price Spread News
8.24 10.52 2.28 - -
Last Trade Time Type Quantity Stock Price Currency
- 0  7.769691 USD

Epigenomics (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 45.77M 5.89M -  -  - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Epigenomics (QX)

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

EPGNY Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology. The company develops and commercializes diagnostic products across multiple cancer indications with high medical need. Epigenomics' lead product, Epi proColon, is a blood-based screening test for the detection of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States, Europe, and China and selected other countries. Epi proLung, a test for lung cancer detection, and HCCBloodTest, a test for liver cancer, have received CE mark in Europe. For more information, visit www.epigenomics.com.


Your Recent History
USOTC
EPGNY
Epigenomic..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.